
|Articles|October 1, 2004
Low-level laser evidence inconclusive
Dallas - Patients' interest in minimally invasive treatments could bode well for the future of low-level laser therapy (LLLT) in the United States, but only if its efficacy can be proven. And current research results are inconclusive, says Murad Alam, M.D., chief, section of cutaneous and aesthetic surgery, department of dermatology, Northwestern University.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
JAK Inhibitors Show Comparable Safety to TNF Antagonists
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5


















